Maternal Diabetes linked to Unique Epigenetic Changes, Potentially Lowering Type 1 Diabetes Risk in Offspring
A new study reveals that children born to mothers with type 1 diabetes (T1D) exhibit distinct epigenetic patterns that may offer a degree of protection against developing teh disease, despite a known increased familial risk. Researchers have long understood the genetic link between family history and T1D, but this research, published in Nature Metabolism, sheds light on why risk varies depending on which parent carries the condition.
For decades, it’s been established that having a first-degree relative with T1D elevates an individual’s risk. However, the latest findings indicate that this risk is substantially lower for those born to a mother with T1D compared to those with a father or sibling affected by the autoimmune condition. The underlying cause of this disparity has remained elusive – untill now.
Unraveling the Epigenetic Code
The research team, led by investigators at the Helmholtz Munich Institute for Diabetes Research, focused on DNA methylation, a process that alters gene expression without changing the underlying DNA sequence. “We observed DNA methylation changes at multiple type 1 diabetes susceptibility genes in children born to mothers with type 1 diabetes,” explained a senior researcher involved in the study.
Crucially, the team found that while genetic susceptibility is comparable between children of mothers and fathers with T1D, the differing risk levels point to epigenetic programming occurring early in life. This suggests that environmental factors within the womb – such as maternal stress or smoking – can induce genetic changes impacting disease risk.
Large-Scale Epigenome Analysis
To investigate this further,researchers analyzed blood DNA samples from 1,752 children enrolled in two prospective longitudinal studies focused on infants at increased risk of T1D. They performed epigenome-wide association studies (EWAS), comparing 790 children with a mother with T1D to 962 children with a mother without the condition.
The EWAS revealed significant differences in DNA methylation at multiple genetic locations, especially within the Homeobox A gene cluster and the major histocompatibility complex (MHC) region. “The MHC region is known to confer the major genetic susceptibility and resistance to type 1 diabetes,” noted the study’s first author. “We observed that the epigenomic changes in these children were associated with the expression of 15 type 1 diabetes susceptibility genes.”
A ‘Methylation Propensity Score’ for risk Assessment
The team developed a “methylation propensity score” based on 34 differentially methylated positions linked to maternal T1D exposure. Applying this score to children without a mother with T1D revealed a compelling correlation: lower scores were associated with the development of islet autoimmunity, an early indicator of T1D. This suggests that a lesser degree of protective epigenetic modifications increases vulnerability to the disease.
In essence, the study demonstrates that environmental factors can influence T1D risk thru epigenetic alterations in key susceptibility genes. The investigators concluded that these findings support the idea that environmental factors affect the risk of islet autoimmunity through epigenetic changes to certain susceptibility genes.
Future Implications for Prediction and Prevention
The newly developed methylation score system holds promise as a tool for assessing individual T1D risk. Researchers believe it could be integrated into existing polygenic risk scores, which currently predict islet immunity. Furthermore, the possibility of using therapeutics or lifestyle modifications to alter DNA methylation and potentially reduce T1D risk is now being explored.
“Future studies should examine the potential for therapeutic intervention into the DNA methylation processes we identified,” a lead scientist stated. However, the researchers also acknowledge the need for further investigation with a more diverse patient population, as the current study primarily included individuals of European descent. Additional studies should also include a more diverse patient population, as the majority of people in the two cohorts used in this study were of European descent.
